At a glance
- Originator NicOx
- Class Erectile dysfunction therapies; Piperazines; Small molecules
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Erectile dysfunction
Most Recent Events
- 27 Jul 2012 Discontinued - Preclinical for Erectile dysfunction in France (unspecified route)
- 09 Dec 2003 No development reported - Preclinical for Erectile dysfunction in France (unspecified route)
- 04 Oct 2001 New profile